A detailed history of Peregrine Capital Management LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 298,105 shares of BLFS stock, worth $7.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
298,105
Previous 297,456 0.22%
Holding current value
$7.9 Million
Previous $6.37 Million 17.05%
% of portfolio
0.23%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$19.19 - $26.52 $12,454 - $17,211
649 Added 0.22%
298,105 $7.46 Million
Q2 2024

Jul 29, 2024

BUY
$15.14 - $22.99 $58,576 - $88,948
3,869 Added 1.32%
297,456 $6.37 Million
Q1 2024

Apr 26, 2024

BUY
$15.35 - $18.82 $1,535 - $1,882
100 Added 0.03%
293,587 $5.45 Million
Q4 2023

Jan 26, 2024

SELL
$8.99 - $16.86 $455,460 - $854,178
-50,663 Reduced 14.72%
293,487 $4.77 Million
Q3 2023

Oct 19, 2023

SELL
$10.81 - $22.96 $233,614 - $496,188
-21,611 Reduced 5.91%
344,150 $4.75 Million
Q2 2023

Jul 26, 2023

SELL
$17.19 - $24.34 $1,942 - $2,750
-113 Reduced 0.03%
365,761 $8.08 Million
Q1 2023

Apr 26, 2023

BUY
$17.67 - $26.07 $1.42 Million - $2.09 Million
80,226 Added 28.09%
365,874 $7.96 Million
Q4 2022

Jan 10, 2023

SELL
$16.95 - $25.07 $146,549 - $216,755
-8,646 Reduced 2.94%
285,648 $5.2 Million
Q3 2022

Oct 26, 2022

SELL
$14.64 - $26.7 $238,280 - $434,569
-16,276 Reduced 5.24%
294,294 $6.7 Million
Q2 2022

Jul 20, 2022

SELL
$10.54 - $24.2 $2,445 - $5,614
-232 Reduced 0.07%
310,570 $4.29 Million
Q1 2022

Apr 27, 2022

SELL
$20.81 - $37.29 $463,584 - $830,709
-22,277 Reduced 6.69%
310,802 $7.07 Million
Q4 2021

Jan 31, 2022

BUY
$32.99 - $58.55 $11 Million - $19.5 Million
333,079 New
333,079 $12.4 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.13B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.